US Archives - Page 96 of 119 - European Medical Journal

Concerns With Pediatric Pneumonia Treatment In The U.S. Revealed

Critical insights into outpatient antibiotic use and treatment failure rates among U.S. children diagnosed with pneumonia, underscoring significant gaps in care, have been revealed in a new study.

Why India Struggles to Treat Child Diarrhea

A recent study led by U.S.-based researchers and published in reveals critical gaps in the quality of healthcare for child diarrhea in India, where simple, affordable treatments are often neglected.

Can Food Choices Treat Acne?

Nutritional and microbial strategies are emerging as pivotal in treating skin conditions such as acne, alopecia, and atopic dermatitis.

Psychological Stress News: Meditation as Effective as Escitalopram

Mindfulness-based stress reduction (MBSR) could match the effectiveness of the commonly prescribed antidepressant escitalopram in treating anxiety disorders, according to the latest psychological stress news.

Walking Pneumonia Increasing In Children

A significant increase in walking pneumonia cases among children, largely attributed to Mycoplasma pneumoniae infections, is drawing attention from U.S. healthcare professionals.

Can Antibiotics Influence Parkinson’s Disease Risk?

A new study examining the effects of antimicrobial exposure on Parkinson’s disease (PD) risk has revealed insights that could influence prescribing decisions, especially concerning antibiotics and antifungal medications.

How Estrogen Weakens Immune Defenses in Cancer

A recent study sheds light on how estrogen signaling affects immune response in breast cancer, potentially opening pathways for combined anti-estrogen and immunotherapy approaches.

Immune Therapy Shows Cancer-Free Survival For 10 Years

Nearly half of patients with metastatic melanoma treated with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab have survived cancer-free, underscoring the impact of immunotherapy in advanced melanoma.

Duloxetine Recalled Due to Cancer Risks

Duloxetine, a widely used and popular antidepressant, has been recalled by U.S. Food and Drug Administration (FDA) due to the detection of N-nitroso-duloxetine, a chemical suspected of being carcinogenic.

Chronic Pain Progresses 1 Year After Whiplash Injury

Hippocampal functional connectivity may be an early indicator of chronic pain development in patients following whiplash and mild traumatic brain injuries (mTBIs) according to the results of a new study.